Skip to main content
Pharma Equity Group A/S logo

Pharma Equity Group A/S — Investor Relations & Filings

Ticker · BLVIS ISIN · DK0061155009 LEI · 2138008SUI4D917FKN20 CO Financial and insurance activities
Open in API
Filings indexed 1,627 across all filing types
Latest filing 2013-12-10 Capital/Financing Update
Country DK Denmark
Listing CO BLVIS

About Pharma Equity Group A/S

https://bcbsfepvision.com/

Pharma Equity Group A/S is an investment company specializing in early-stage biotechnology, life science, and MedTech companies. The group's mission is to support its portfolio companies in developing novel therapies and effective medicines for unmet medical needs. A primary investment is its subsidiary, Reponex Pharmaceuticals, a clinical-stage biopharmaceutical company focused on developing treatments for serious, acute, and chronic inflammatory diseases. The company is actively expanding its portfolio through strategic acquisitions to support its growth.

Recent filings

Filing Released Lang Actions
Capital/Financing Update 2013
Capital/Financing Update Classification · 99% confidence The document is a short official announcement (2187 characters) dated December 10, 2013, from Blue Vision A/S. It discusses ongoing discussions with major shareholders (Kiwi Deposit Holdings A/S and ALMC, hf) regarding the potential transfer of their shareholdings and the conversion/transfer of significant loans provided to the company. The core topic is the restructuring of equity and future financing structure. This relates directly to capital structure changes and financing activities. Given the options, 'Capital/Financing Update' (CAP) is the most appropriate classification, as it details active steps being taken to resolve the company's capital situation, rather than just announcing a report (RPA/RNS) or a dividend (DIV).
2013-12-10 Danish
Environmental & Social Information 2013
Environmental & Social Information Classification · 99% confidence The document is a 'SELSKABSMEDDELELSE' (Company Announcement) from Blue Vision A/S dated December 10, 2013. It details the sale of real estate assets (Ejendommen) by a subsidiary to another entity for DKK 24,000,000. This transaction involves a significant change in the company's asset structure and is a material event announcement. It is not a standard periodic report (10-K, IR, ER), a management change (MANG), or a dividend notice (DIV). Since it concerns a major transaction/asset disposal that affects the company's structure and future operations, it fits best under Capital/Financing Update (CAP) as it relates to a significant asset transaction, or potentially Regulatory Filings (RNS) if no other specific category applies. Given the nature of selling a major asset, CAP is the most appropriate fit among the specific options, as it relates to capital structure/asset base changes, although it is not a typical fundraising event. If the transaction were purely administrative or minor, RNS would be used. Since it's a material asset sale, CAP is selected.
2013-12-10 English
M&A Activity 2013
M&A Activity Classification · 95% confidence The document text describes an agreement between two parties (Roret, Snekkersten ApS and A/S Bolig Snekkersten) for the sale of specific real estate properties (Ejendommen) for a cash consideration of DKK 24,000,000. This transaction involves the transfer of assets between related entities (subsidiaries of Blue Vision A/S). This type of corporate action, specifically the sale or acquisition of significant assets, falls under the category of M&A Activity or a significant corporate transaction. Given the options, 'M&A Activity' (TAR) is the most appropriate classification for a material asset sale/transfer, even if it's an internal group restructuring or sale to an external party. The document is short (1389 chars) and contains the substance of the transaction, not just an announcement of a report, so RPA/RNS is less likely than TAR.
2013-12-10 Danish
Capital/Financing Update 2013
Capital/Financing Update Classification · 99% confidence The document is a formal announcement dated October 22, 2013, from Blue Vision A/S regarding a loan agreement termination and immediate repayment demand by Kiwi Deposit Building Society. It discusses a DKK 60,000,000 facility, the current outstanding balance (DKK 16,853,738.19), and the company's legal stance on the termination and enforceability of the debt. This content relates to financing activities, debt restructuring, and potential legal/financial disputes. Since it is a specific announcement about a financing event (loan termination/demand for repayment) and not a general regulatory filing, a major shareholding change, or a dividend notice, the most appropriate category is 'Capital/Financing Update' (CAP). It is too specific for the general 'Regulatory Filings' (RNS) fallback.
2013-10-22 Danish
Legal Proceedings Report 2013
Legal Proceedings Report Classification · 99% confidence The document is a short announcement (1618 characters) dated September 30, 2013, from Blue Vision A/S. It refers to a previous announcement regarding the sale of a subsidiary and the resulting negative equity situation. Crucially, it states that discussions with key shareholders regarding recapitalization are ongoing and that the expected announcement of the results has been postponed from Q3 2013 to Q4 2013. This is a formal update on a financial/capital structure matter and a delay in providing further information, but it is not the full financial report (10-K or IR) nor the final result of the financing discussions. Since it is an update concerning capital structure and financing discussions following a major transaction, it fits best under 'Capital/Financing Update' (CAP). It is too specific for the general 'Regulatory Filings' (RNS) and does not fit any other category like ER, DIV, or DIRS.
2013-09-30 Danish
Interim / Quarterly Report 2013
Interim / Quarterly Report Classification · 100% confidence The document is a 'Selskabsmeddelelse' (Company Announcement) from Blue Vision A/S, which explicitly states it is the 'delårsrapporten' (interim report) for the period 1 January to 30 June 2013. It contains substantive financial data, including profit/loss figures, equity status, and management commentary on business trends and events. It meets the criteria for an Interim/Quarterly Report (IR) as it provides actual financial statements and analysis for a period shorter than a full fiscal year. H1 2013
2013-08-16 Danish

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.